Viewing Study NCT04663035


Ignite Creation Date: 2025-12-24 @ 10:17 PM
Ignite Modification Date: 2025-12-25 @ 7:51 PM
Study NCT ID: NCT04663035
Status: UNKNOWN
Last Update Posted: 2023-03-22
First Post: 2020-12-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Ablation Plus Tislelizumab Versus Ablation Alone for Intrahepatic Recurrent Early Stage HCC
Sponsor: Ming Zhao
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module